Screening for Anderson-Fabry Disease in patients with left ventricular hypertrophy and disease-related red flags

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Joana Certo Pereira

Hospital de Santa Cruz, Carnaxide (Portugal)

7 More presentations in this session

Presentation thumbnail

Cardiovascular prognostic determinants in anderson-fabry disease: insights from a multicenter cohort study

Doctor Y. Chen (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

FollowME Fabry Pathfinders real-world registry in Spain and Portugal: cardiac and renal outcomes with migalastat in patients with Fabry disease

Professor O. Azevedo (Guimaraes, PT)

Abstract Slides Video

Presentation thumbnail

Apical hypertrophic cardiomyopathy: could it be Fabry?

Doctor S. Findlay (Cambridge, GB)

Abstract Slides Video

Presentation thumbnail

Prevalence of pseudo-delta wave in Anderson-Fabry disease and challenges in differentiating from ventricular pre-excitation

Doctor S. Serratore (Catanzaro, IT)

Abstract Slides Video

Presentation thumbnail

Fabry disease screening in patients with idiopathic HCM or idiopathic LVH: preliminary data from the multicentric nationwide F-CHECK study

Doctor E. Martins (Porto, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Fabry disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Fabry disease screening in patients with idiopathic HCM or idiopathic LVH: preliminary data from the multicentric nationwide F-CHECK study

Congress Presentation

The spectrum of hypertrophic cardiomyopathies: where is fabry

Congress Presentation

Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources